SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Foster James Alexander Cunliffe
(Last) (First) (Middle)
BIOCITY GLASGOW BO'NESS ROAD
NEWHOUSE LANARKSHIRE
(Street)
MOTHERWELL LANARKSHIRE ML1 5UH
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
Virax Biolabs Group Ltd [ VRAX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 287,987 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) (1) 07/20/2032 Ordinary Shares 37,250 50 D
Stock Options (right to buy) (2) 04/18/2033 Ordinary Shares 40,000 6 D
Stock Options (right to buy) (3) 04/18/2034 Ordinary Shares 50,000 0.68 D
Stock Options (right to buy) (4) 04/08/2035 Ordinary Shares 18,025 0.88 D
Stock Options (right to buy) (5) 04/08/2035 Ordinary Shares 31,975 0.88 D
Explanation of Responses:
1. On July 20, 2022, the Company granted 37,250 stock options under the Company's 2023 Equity Incentive Plan. The stock options are fully vested.
2. On April 18, 2023, the Company granted 40,000 stock options under the Company's 2023 Equity Incentive Plan. The options vest in equal thirds on April 18 of each of 2024, 2025, and 2026. The vested portions of such options will become exercisable upon vesting.
3. On April 18, 2024, the Company granted 50,000 stock options under the Company's 2023 Equity Incentive Plan. The options vest in equal thirds on April 18 of each of 2025, 2026, and 2027. The vested portions of such options will become exercisable upon vesting.
4. On April 8, 2025, the Company granted 18,025 stock options under the Company's 2024 Equity Incentive Plan. The options vest in equal thirds on April 8 of each of 2026, 2027, and 2028. The vested portions of such options will become exercisable upon vesting.
5. On April 8, 2025, the Company granted 31,975 stock options under the Company's 2024 Equity Incentive Plan. The options vest in equal thirds on April 8 of each of 2026, 2027, and 2028. The vested portions of such options will become exercisable upon vesting.
/s/ James Foster 03/18/2026
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.